Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Sinochem International Corporation (600500.SS)
Shanghai, CN
Operating globally, Sinochem International Corporation specializes in a diverse portfolio encompassing advanced materials, agricultural chemicals, polymer enhancement additives, and natural rubber production. Within its new materials division, the company provides a range of innovative products such as polycarbonates, polystyrenes, dyed pigments, ABS resins, polyurethanes, and forest greases. It also supplies thermoplastics crucial for the automotive, medical, electrical equipment, and electronic engineering sectors, alongside high-performance fibers. Furthermore, Sinochem International manufactures advanced membrane technologies—including reverse osmosis, nanofiltration, degassed, and electro-driven ionic membranes—utilized across a broad spectrum of water treatment applications, from zero liquid discharge and wastewater recycling to seawater desalination, brackish water treatment, ultrapure water production, and general domestic water purification. The firm's offerings extend to various polymer additives, including rubber antioxidants, insoluble sulfur, vulcanizing accelerators for rubber, and nitrobenzene. Moreover, it is a key supplier of lithium battery materials, serving the portable electronics, power tool, and New Energy Vehicle (NEV) industries, in addition to producing EV battery cells specifically for electric vehicles. Beyond materials, Sinochem International delivers a suite of agricultural chemicals and comprehensive solutions designed to boost crop yield and quality for farmers. These include active pharmaceutical ingredients (APIs), specialized preparations, advanced fine chemical intermediates, herbicides, pesticides, and fungicides. The company is also active in the healthcare sector, engaging in the research, production, and distribution of medical equipment, raw nutritional ingredients, and food additives. Its medical focus spans pharmaceuticals and devices tailored for orthopedics, cardiology, gastroenterology, and neurosurgery. Furthermore, it manages the production and commercialization of natural rubber. To support its diverse operations, Sinochem International maintains a network of production facilities for intermediates and new materials, alongside state-of-the-art laboratories and extensive analysis and testing centers. Established in 1998, the corporation is headquartered in Shanghai, People's Republic of China, and functions as a subsidiary of Sinochem Corporation.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.19% | +6.80% | +16.40% | +15.11% | +18.00% | +32.14% | +39.62% | -17.91% | -15.22% | -24.16% | +100.78% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 1 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Conglomerates: +6.1%-10.6% Q1'26: -10.2% (vs Q1'25)
-
EPS growth Conglomerates: +16.9%+21.5% ★ Q1'26: +45.5% (vs Q1'25)
-
FCF margin FCF growth · Conglomerates: +35.9%-2.2% Q1'26: +1.8% (vs Q1'25)
-
EBIT margin Conglomerates: +9.0%-3.1% Q1'26: -1.1% (vs Q1'25)
-
ROIC Conglomerates: +4.7%-3.8% Q1'26: -1.2% (vs Q1'25)
-
Share dilution Conglomerates: +0.0%-0.1% ★ Q1'26: -0.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Conglomerates: 1.28×24.82× Q1'26: -53.01× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
43.75B
est: 41.58B (+5.2%)
|
53.87B
est: 43.18B (+24.8%)
|
55.24B
est: 50.39B (+9.6%)
|
59.96B
est: 67.46B (-11.1%)
|
53.23B
est: 50.96B (+4.5%)
|
54.16B
est: 53.93B (+0.4%)
|
80.78B
est: 71.10B (+13.6%)
|
87.45B
est: 77.38B (+13.0%)
|
54.27B
est: 89.51B (-39.4%)
|
52.93B
est: 63.06B (-16.1%)
|
47.32B
est: 60.95B (-22.4%)
|
62.37B
62.37B – 62.37B
+2.3% YoY
|
64.03B
64.03B – 64.03B
+2.7% YoY
|
| EBITDA |
2.20B
est: 1.76B (+25.4%)
|
2.50B
est: 1.82B (+37.0%)
|
2.95B
est: 2.13B (+38.4%)
|
3.92B
est: 2.85B (+37.5%)
|
3.46B
est: 2.15B (+60.7%)
|
3.99B
est: 2.28B (+75.1%)
|
4.86B
est: 3.00B (+61.9%)
|
4.29B
est: 3.27B (+31.3%)
|
946.72M
est: 3.78B (-75.0%)
|
575.35M
est: 2.04B (-71.7%)
|
1.13B
est: 1.97B (-42.7%)
|
2.01B
2.01B – 2.01B
+2.3% YoY
|
2.07B
2.07B – 2.07B
+2.7% YoY
|
| EBIT |
1.14B
est: 505.29M (+125.1%)
|
1.32B
est: 524.79M (+152.1%)
|
1.61B
est: 612.43M (+163.2%)
|
2.46B
est: 819.89M (+199.9%)
|
2.14B
est: 619.31M (+245.2%)
|
2.42B
est: 655.37M (+269.2%)
|
3.36B
est: 864.04M (+288.5%)
|
2.68B
est: 940.37M (+184.6%)
|
-1.19B
est: 1.09B (-209.5%)
|
-1.81B
est: -192.86M (-836.1%)
|
-1.48B
est: -186.42M (-696.5%)
|
-190.74M
-190.74M – -190.74M
-2.3% YoY
|
-195.81M
-195.81M – -195.81M
-2.7% YoY
|
| Net Income |
473.04M
est: 1.15B (-58.7%)
|
187.33M
est: 379.78M (-50.7%)
|
648.05M
est: 915.62M (-29.2%)
|
911.09M
est: 1.35B (-32.3%)
|
476.28M
est: 718.13M (-33.7%)
|
306.87M
est: 718.13M (-57.3%)
|
2.15B
est: 3.38B (-36.2%)
|
1.31B
est: 1.65B (-20.7%)
|
-1.85B
est: 574.50M (-421.6%)
|
-2.84B
est: 215.21M (-1,418.0%)
|
-2.22B
est: -1.40B (-58.9%)
|
-466.30M
-466.30M – -466.30M
+66.7% YoY
|
35.87M
35.87M – 35.87M
+107.7% YoY
|
| SGA |
2.46B
est: 1.72B (+43.2%)
|
3.18B
est: 1.79B (+77.9%)
|
3.44B
est: 2.08B (+65.0%)
|
3.48B
est: 2.79B (+24.6%)
|
3.38B
est: 2.11B (+60.1%)
|
3.09B
est: 2.23B (+38.4%)
|
3.19B
est: 2.94B (+8.5%)
|
2.81B
est: 3.20B (-12.3%)
|
2.22B
est: 3.70B (-40.0%)
|
1.98B
est: 2.32B (-15.0%)
|
1.63B
est: 2.25B (-27.5%)
|
2.30B
2.30B – 2.30B
+2.3% YoY
|
2.36B
2.36B – 2.36B
+2.7% YoY
|
| EPS |
0.18
est: 0.32 (-44.6%)
|
0.07
est: 0.11 (-34.6%)
|
0.24
est: 0.26 (-5.9%)
|
0.34
est: 0.37 (-9.2%)
|
0.18
est: 0.20 (-12.1%)
|
0.11
est: 0.20 (-43.4%)
|
0.77
est: 0.94 (-17.8%)
|
0.46
est: 0.46 (+0.1%)
|
-0.52
est: 0.16 (-425.0%)
|
-0.79
est: 0.06 (-1,416.7%)
|
-0.62
est: -0.39 (-59.0%)
|
-0.13
-0.13 – -0.13
+66.7% YoY
|
0.01
0.01 – 0.01
+107.7% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-11 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-08 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-07 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Franklin FTSE China UCITS ETF FLXC.L | 0.00% | 66.7K | 0.19% |
| 2 | Dimensional - Emerging Markets Value ETF DFEV | 0.00% | 52.8K | 0.46% |
| 3 | Schwab Emerging Markets Equity ETF SCHE | 0.00% | 328.4K | 0.06% |
| 4 | FlexShares Morningstar Emerging Markets Factor Tilt Index Fund TLTE | 0.00% | 8.9K | 0.58% |
| 5 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 245.7K | 0.28% |
| 6 | Vanguard FTSE Emerging Markets UCITS ETF (USD) Accumulating VFEA.L | 0.00% | 112.5K | 0.17% |
| 7 | Vanguard FTSE Emerging Markets UCITS ETF (USD) Distributing VDEM.L | 0.00% | 112.5K | 0.17% |
| 8 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 23.7K | 0.48% |
| 9 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 53.4K | 0.26% |
| 10 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 161.2K | 0.29% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Chee-Hwa Dong | Deputy General Manager | — | male |
| Guoyu Fang | Deputy General Manager | — | male |
| Hai Lan | Chief Financial Officer & Head of Accounting | — | male |
| Hongbo Chen | Deputy General Manager | — | male |
| Jiang Pu | Board Secretary | — | male |
| Xiaolin Pang | GM & Director | — | male |
| Xiting Ke | Secretary of the Board | — | male |
| Yinghua Zhou | Deputy General Manager | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 600500.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
